Tubal ektopik gebeliklerde çoklu doz metotreksat tedavisinin analizi

Yıl 2022, Cilt: 47 Sayı: 1, 397 - 404, 31.03.2022

Furkan Çetin Neslihan Bayramoğlu Tepe Seyhun Sucu Muhammed Hanifi Bademkıran İrfan Kutlar

https://doi.org/10.17826/cumj.1037172

Öz

Amaç: Tubal ektopik gebelik hastalarında ardışık çoklu doz metotreksat tedavisinin başarı oranı ile tedavi başarısına etki eden prognostik faktörlerin belirlenmesi hedeflenmiştir.
Gereç ve Yöntem: Bu retrospektif çalışmada 2017-2020 yılları arasında tersiyer merkezimizde ektopik gebelik tanısı ile hospitalize edilmiş ve ardışık çoklu doz metotreksat tedavi protokolü uygulanmış 63 hastanın klinik, labaratuvar ve demografik verileri analiz edilmiştir.
Bulgular: Hastaların 45’inde medikal tedavi ile başarılı olunmuştur. Metotreksat protokolü ile başarısız olunan hastaların %88.8’inde (n=16) takip sırasında tubal rüptür nedeni ile cerrahi operasyon ihtiyacı gelişmiştir. Medikal tedavi ile başarılı olunan grupta başvuru anında Douglas’ta serbest mayi ortalaması 2.40±0.70 mm (Ort.±SH); başarısız olunan grupta 10.38±3.05 mm (Ort.±SH) bulunmuştur. Medikal tedavi ile başarılı olunan grubun başvuru β-hCG düzeyi 3668.55±440.55 IU/L (Ort.±SH); başarısız olunan grubunki 4929.72±752.65 IU/L (Ort.±SH) bulunmuştur.
Sonuç: Ardışık çoklu doz metotreksat protokolünün başarı oranı %71.4 olarak saptanmıştır. Medikal tedavi ile başarısız olunan grupta başlangıç serum β-hCG düzeyinin yüksek olduğu, yine ilk başvuruda Douglas’ta sonografik olarak ölçülen serbest sıvı miktarının yüksek olduğu tespit edilmiştir.

Anahtar Kelimeler

Metotreksat, Dış Gebelik, Tubal Rüptür

Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies

Öz

Purpose: The study aimed at determining the success rate of sequential multi-dose methotrexate treatment in tubal ectopic pregnancy (EP) patients and the prognostic factors affecting the treatment success.
Materials and Methods: Clinical, laboratory, and demographic data of 63 patients -hospitalized with the diagnosis of EP in our tertiary center between 2017-2020 and administered sequential multiple-dose methotrexate treatment protocol- were analyzed in this retrospective study.
Results: Based on research findings, medical treatment was successful in 45 of the patients. It was found that 16 out of 18-patient, 88.8% of the patients in the failed group with methotrexate treatment, were operated on due to tubal rupture during follow-up. The mean of sonographic free fluid in Douglas of the successful group with methotrexate treatment was found to be 2.40±0.70 mm (Mean±SE), while it was 10.38±3.05 mm (Mean±SE) in the failed group at the first consultation. The initial β-hCG value of the successful group with methotrexate treatment was measured 3668.55±440.55 IU/L (Mean±SE), while it was 4929.72±752.65 IU/L (Mean±SE) in the failed group.
Conclusion: The success rate of the sequential multiple dose methotrexate protocol was 71.4%. Both the initial serum β-hCG level and the amount of sonographic free fluid in the pouch of Douglas were found high in the failed group with medical treatment at the first consultation.

Anahtar Kelimeler

Methotrexate, Ectopic Pregnancy, Tubal Rupture

Kaynakça

• Eriç HJ, Görkemli H, Özkaya EB, Işıkalan MM, Akıncı D, Kılıç F. Ektopik gebelik ve düşük tehdidi tanısında hemogram parametrelerinin değerlendirilmesi. Cukurova Med J. 2021;46:63-9.
• Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J.. Ectopic Pregnancy. In Williams Obstetrics, 24th ed., New York, McGraw-Hill, 2014.
• Desroque D, Capmas P, Legendre G, Bouyer J, Fernandez H. Fertility after ectopic pregnancy. J Gynecol Obstet Biol Reprod (Paris). 2010;39:395-400.
• Spandana J, Tejaswini D, Bai GS. Clinical course of ectopic pregnancy: a tertiary centre experience. Int J Reprod Contracept Obstet Gynecol. 2017;6:2990-7.
• Baselice J, Yates M. Ectopic pregnancy. In The Johns Hopkins Manual of Gynecology and Obstetrics (Eds Hurt KJ, Guile MW, Bienstock JL, Fox HE, Wallach EE):340-9. New York, Lippincott Williams & Wilkins, 2012.
• van Mello NM, Mol F, Ankum WM, Mol BW, van der Veen F, Hajenius PJ. Ectopic pregnancy: how the diagnostic and therapeutic management has changed. Fertil Steril. 2012;98:1066-73.
• Creanga AA, Shapiro-Mendoza CK, Bish CL, Zane S, Berg CJ, Callaghan WM. Trends in ectopic pregnancy mortality in the United States: 1980-2007. Obstet Gynecol. 2011;117:837-43.
• Dhar H, Hamdi I, Rathi B. Methotrexate treatment of ectopic pregnancy: experience at nizwa hospital with literature review. Oman Med J. 2011;26:94-8.
• Thacker J, Reardon R. Sonographic free fluid in patients with ectopic pregnancy. Ann Emerg Med. 2004;44:85.
• Sargin MA, Yassa M, Taymur BD, Çelik A, Aydin S, Orhan E et al. A clinical experience of ectopic pregnancies with initial free intraperitoneal fluid. J Clin Diagn Res. 2016;10:22-6.
• Phatak S, Shrivastav D, Marfani G, Daga S, Madurwar K, Samad S. Transvaginal sonography and elastography evaluation of ectopic pregnancy. J Datta Meghe Instit Med Sci Univ. 2019;14:86-9.
• Practice Committee of American Society for Reproductive Medicine. Medical treatment of ectopic pregnancy: a committee opinion. Fertil Steril. 2013;100:638-44.
• Gnisci A, Stefani L, Bottin P, Ohannessian A, Gamerre M, Agostini A. Predictive value of hemoperitoneum for outcome of methotrexate treatment in ectopic pregnancy: an observational comparative study. Ultrasound Obstet Gynecol. 2014;43:698-701.
• Moini A, Hosseini R, Jahangiri N, Shiva M, Akhoond MR. Risk factors for ectopic pregnancy: a case–control study. J Res Med Sci. 2014;19:844-9.
• Goksedef BP, Kef S, Akca A, Bayik RNE, Cetin A. Risk factors for rupture in tubal ectopic pregnancy: definition of the clinical findings. Eur J Obstet Gynecol Reprod Biol. 2011;154:96-9.
• Roya FD, Maryam A, Nastaran FP, Ali AA. Predictive value of maternal serum beta-hCG concentration in the ruptured tubal ectopic pregnancy. Iran J Reprod Med. 2015;13:101-6.
• Lawlor DA, Mortensen L, Andersen AM. Mechanisms underlying the associations of maternal age with adverse perinatal outcomes: a sibling study of 264 695 Danish women and their firstborn offspring. Int J Epidemiol. 2011;40:1205-14.
• Bonin L, Pedreiro C, Moret S, Chene G, Gaucherand P, Lamblin G. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: a comparative study of 400 cases. Eur J Obstet Gynecol Reprod Biol. 2017;208:23-30.
• Bowman ZS, Smith KR, Silver RM. Cesarean delivery and risk for subsequent ectopic pregnancy. Am J Perinatol. 2015;32:815-20.
• Olooto WE, Amballi AA, Banjo TA. A review of female infertility; important etiological factors and management. J Microbiol Biotech Res. 2012;2:379-85.
• Sindiani AM, Alshdaifat E, Obeidat B, Obeidat R, Rawashdeh H, Yaseen H. The use of single dose methotrexate in the management of ectopic pregnancy and pregnancy of unknown location: 10 years' experience in a tertiary center. Int J Womens Health. 2020;12:1233-39.
• Cohen A, Zakar L, Gil Y, Amer-Alshiek J, Bibi G, Almog B et al. Methotrexate success rates in progressing ectopic pregnancies: a reappraisal. Am J Obstet Gynecol. 2014;211:128.
• Yang C, Cai J, Geng Y, Gao Y. Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis. Reprod Biomed Online. 2017;34:383-91.
• Skubisz MM, Tong S. The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: a review. ISRN Obstet Gynecol. 2012;2012:637094.
• Bachman EA, Barnhart K. Medical management of ectopic pregnancy: a comparison of regimens. Clin Obstet Gynecol. 2012;55:440-7.
• Cecchino GN, Araujo Júnior E, Elito Júnior J. Methotrexate for ectopic pregnancy: when and how. Arch Gynecol Obstet. 2014;290:417-23.
• Hamed HO, Ahmed SR, Alghasham AA. Comparison of double- and single-dose methotrexate protocols for treatment of ectopic pregnancy. International Journal of Gynecology & Obstetrics. 2012;116:67-71.
• Mavrelos D, Nicks H, Jamil A, Hoo W, Jauniaux E, Jurkovic D. Efficacy and safety of a clinical protocol for expectant management of selected women diagnosed with a tubal ectopic pregnancy. Ultrasound Obstet Gynecol. 2013;42:102-7.
• Sudha VS, Thangaraj DR. A retrospective study on ectopic pregnancy: a two year study. Int J Reprod Contracept Obstet Gynecol. 2016;5:4365-9.
• Celik E, Türkçüoğlu I, Karaer A, Kırıcı P, Eraslan S. Assessment of early decline in the percentage of β-hCG values between days 0 and 4 after methotrexate therapy in ectopic pregnancy for the prediction of treatment success. J Turk Ger Gynecol Assoc. 2013;14:125-9.
• Orazulike NC, Konje JC. Diagnosis and management of ectopic pregnancy. Womens Health (Lond). 2013;9:373-85.
• Lee R, Dupuis C, Chen B, Smith A, Kim YH. Diagnosing ectopic pregnancy in the emergency setting. Ultrasonography. 2018;37:78-87.
• Var A, Özyurt R, Şık BA, Kumbasar S, Sever E, Deveci M et al. Retrospective analysis of factors that affect the success of single-dose methotrexate treatment in ectopic pregnancy. Turk J Obstet Gynecol. 2015;12:215-9.
• Lermann J, Segl P, Jud SM, Beckmann MW, Oppelt P, Thiel FC et al. A. Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008. Arch Gynecol Obstet. 2014;289:329-35.
• Sivalingam VN, Duncan WC, Kirk E, Shephard LA, Horne AW. Diagnosis and management of ectopic pregnancy. J Fam Plann Reprod Health Care. 2011;37:231-40.